Recursion Pharmaceuticals

Recursion Pharmaceuticals, founded in 2013 and based in Salt Lake City, Utah, is a clinical-stage TechBio company that leverages artificial intelligence and machine learning to accelerate drug discovery. They utilize their Recursion OS platform, which integrates automated wet lab experiments with computational analysis of cellular images, to identify and develop novel treatments. Their primary focus areas include aggressive cancers and rare diseases with high unmet medical needs. While primarily a drug development firm, Recursion engages in strategic acquisitions of companies that enhance its core AI-driven capabilities in chemistry and generative AI.